EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Multicenter retrospective genomic characterization of carbapenemase-producing Acinetobacter baumannii isolates from Jiangxi patients 2021–2022: identification of a novel international clone, IC11

An Xu iD, Min Li, Yaping Hang, Lingbing Zeng, Xuefei Zhang, Yiyi Hu, Qinglan Guo iD, Minggui Wang iD

mSphere · 25.06.2024 · 9 (6)

DOI: 10.1128/msphere.00276-24 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift mSphere, erschienen am 25.06.2024. Verfasst von An Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Acinetobacter baumannii, beta-Lactamases, Acinetobacter Infections, Bacterial Proteins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China, Jiangxi Applied Development Special Fund for Health Science and Technology Development, The Applied Program of the Health Commission of Jiangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to characterize carbapenem-resistant Acinetobacter baumannii (CRAB) isolates from Jiangxi patients using whole-genome sequencing (WGS). We subjected 100 clinical CRAB strains isolated from the three local largest teaching hospitals to WGS and antimicrobial susceptibility testing. Molecular epidemiology was investigated using multilocus sequence typing, core genome multilocus typing, core genome single-nucleotide polymorphism phylogeny, and pulsed-field gel electrophoresis. The most prevalent acquired carbapenemase was bla OXA-23 , predominant in all isolates (100%). Isolates belonging to the dominating international clone IC2 accounted for 92% of all isolates. International IC11 (ST164 Pas /ST1418 Ox ) clone was found in an additional 8% (eight isolates), with seven isolates (87.5%) carrying an acquired additional bla NDM-1 carbapenemase. The oxa23 -associated Tn 2009 , either alone or in a tandem repeat structure containing four copies of bla OXA-23 , was discovered in 62% (57 isolates) of IC2. The oxa23 -associated Tn 2006 was identified in 38% (35 isolates) of IC2 and all IC11 isolates. A putative conjugative RP-T1 (formerly RepAci6) plasmid with bla OXA-23 in Tn 2006 within AbaR4, designated pSRM1.1, was found in IC2 A. baumannii strain SRM1. The bla NDM-1 gene found in seven IC11 isolates was located on a novel Tn 6924 -like transposon, a first-time report in IC11. These findings underscore the significant importance of real-time surveillance to prevent the further spread of CRAB. IMPORTANCE Carbapenem-resistant Acinetobacter baumannii (CRAB) is notorious for causing difficult-to-treat infections. To elucidate the molecular and clinical epidemiology of CRAB in Jiangxi, clinical CRAB isolates were collected and underwent whole-genome sequencing and antibiotic susceptibility phenotyping. Key findings included the predominance of OXA-23-producing IC2 A. baumannii , marked by the emergence of OXA-23 and NDM-1-producing IC11 strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniibeta-LactamasesAcinetobacter InfectionsBacterial ProteinsWhole Genome SequencingMultilocus Sequence TypingMicrobial Sensitivity TestsAnti-Bacterial AgentsMolecular EpidemiologyHumansRetrospective StudiesCarbapenemsGenome, BacterialPhylogenyMaleFemaleMiddle AgedAgedAdultElectrophoresis, Gel, Pulsed-FieldPlasmidsPolymorphism, Single NucleotideGenomics

Stichwörter der Autor:innen

Carbapenem-resistant Acinetobacter baumanniiIC11IC2blaNDM-1blaOXA-23

Substanzen

beta-LactamasescarbapenemaseBacterial ProteinsAnti-Bacterial AgentsCarbapenems

Autor:innen und Institutionen

  • Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
  • Key Laboratory of Clinical Pharmacology of Antibiotics, National Health Commission of People's Republic of China, Shanghai, China.
  • Department of Neurology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

ORCID-Profile: An Xu, Qinglan Guo, Minggui Wang

Förderung

  • MOST | National Natural Science Foundation of China
  • Jiangxi Applied Development Special Fund for Health Science and Technology Development
  • The Applied Program of the Health Commission of Jiangxi Province

Zitieren

APA

Xu, A., Li, M., Hang, Y., Zeng, L., Zhang, X., Hu, Y., Guo, Q., & Wang, M. (2024). Multicenter retrospective genomic characterization of carbapenemase-producing Acinetobacter baumannii isolates from Jiangxi patients 2021–2022: identification of a novel international clone, IC11. mSphere, 9(6). https://doi.org/10.1128/msphere.00276-24

Vancouver

Xu A, Li M, Hang Y, Zeng L, Zhang X, Hu Y, et al. Multicenter retrospective genomic characterization of carbapenemase-producing Acinetobacter baumannii isolates from Jiangxi patients 2021–2022: identification of a novel international clone, IC11. mSphere. 2024;9(6). doi:10.1128/msphere.00276-24

BibTeX
@article{Xu2024,
  author = {Xu, An and Li, Min and Hang, Yaping and Zeng, Lingbing and Zhang, Xuefei and Hu, Yiyi and Guo, Qinglan and Wang, Minggui},
  title = {Multicenter retrospective genomic characterization of carbapenemase-producing Acinetobacter baumannii isolates from Jiangxi patients 2021–2022: identification of a novel international clone, IC11},
  journal = {mSphere},
  year = {2024},
  volume = {9},
  number = {6},
  doi = {10.1128/msphere.00276-24}
}
Kostenlos starten →